Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
1
Mins
29th June 2020
Genetics May Alter Skin Microbiome and Affect Wound Healing
DIVERSITY of the skin’s bacterial microbiome may depend upon genetic factors that help to determine healing in chronic wounds.
1
Mins
29th June 2020
New Treatment Patch Option for Skin Cancer
INNOVATIVE development of a novel wearable patch for topical delivery of treatment for melanoma may lead to a better treatment experience for patients.
2
Mins
29th June 2020
Traumatic Coronary Artery Dissection Diagnosed Immediately with Cardiac CT
The incidence of traumatic coronary artery dissection is rare, but it can be life-threatening…
Chief Digital Officers: the pioneers of cultural change
Meet the Chief Digital Officer: a person that ensures a pharmaceutical company evolves with the times through continued collaboration and culture shifts.
The metrics of medical affairs
Measuring the impact of medical affairs is less straightforward than it is for R&D or commercial, but we must establish success metrics.
Creating brand loyalty with RWE
The commercial value of RWE is yet to be realised, but the benefits extend far beyond the aisles in which it is currently in high demand.
Calling checkmate on meaningless social media
The pharma industry is dabbling in the game of social media, and it’s no secret that they need to have a better presence on these platforms.
Digital therapeutics: fad or force for change?
More and more digital therapeutics are hitting the market, taking the patient experience of healthcare into a more innovative, less invasive place, but are these digital devices worth the hype?
Talking to Dr Gino Martini
Dr Gino Martini, Chief Scientist, Royal Pharmaceutical Society, covers the rapid data generation of COVID-19, the value of digital for HCPs, and why he thinks there will be much to reflect on after the pandemic has passed.
3
Mins
23rd June 2020
Newborn Screening: Now and in the Future
WHAT is the value of newborn screening (NBS) to the rare diseases community?…
←
1
2
3
…
452
453
454
455
456
457
458
…
866
867
868
→